99mTc-polyphosphonate labelling – Enhancement of a novel method for the quantification of osteogenic differentiation of MSCs in vitro. (October 2022)

• Record Type: Journal Article
• Authors: Grossner, Tobias; Helbig, Lars; Schmidmaier, Gerhard; Haberkorn, Uwe; Gotterbarm, Tobias
• Is Part Of: Injury. Volume 53(2022)Supplement 2
• Page Start: S34
• Page End: S39
• Publication Date: 2022-10
• Subjects: Osteogenic differentiation -- Hydroxyapatite quantification -- 99mTechnetium -- Methylene diphosphonate -- Hydroxydiphosphonate -- 2, 3-Dicarboxypropane-1, 1-diphosphonate; Wounds and injuries -- Surgery -- Periodicals; Accidents -- Periodicals; Wounds and Injuries -- surgery -- Periodicals; Lésions et blessures -- Chirurgie -- Périodiques; Electronic journals; Electronic journals; 617.1
• DOI: 10.1016/j.injury.2020.12.017
• Languages: English
• ISSNs: 0020-1383

Abstract

Highlights : This study assesses the usability of a variety of tracers for a recently developed, highly sensitive, quantitative and non-destructive method for evaluating the in vitro amount of mineral produced by osteogenic differentiated mesenchymal stem cells in a monolayer cell culture using the radioactive tracer 99 m Technetium. The presented results suggest that the novel method works superbly with all three commercially available 99 m Technetium tracers (MDP, DPD, HDP) and therefore this method can be used worldwide. Furthermore, the timepoint when the labelling is performed is of little importance, which makes the planning and scheduling of osteogenic stem cell experiments more flexible. Abstract: Bone tissue engineering is a fast-growing field in regenerative medicine. Consequently, there is a high demand for new, fast and reliable methods to track and quantify the osteogenic differentiation of cells. Recently, a novel method was published to non-destructively quantify the hydroxyapatite content of monolayer and 3-dimensional mesenchymal stem cell cultures using the ability of 99 m Technetium-methylene diphosphonate (MDP), a well-established tracer in clinical nuclear medicine, to bind to newly synthesized hydroxyapatite. In the present study, two other commonly used 99 m Technetium tracers, 2, 3-dicarboxypropane-1, 1-diphosphonate (DPD) and hydroxydiphosphonate (HDP), were evaluated to see if they could also be used for the same purpose. Furthermore, we investigated if labelling at various timepoints influenced the effectiveness of the labelling. The results were analysed using one-factor ANOVA followed by Bonferroni post-hoc testing. This revealed a highly significant difference between the three osteogenic groups at each timepoint compared to their corresponding negative controls. However, there was no statistically significant difference between the three different tracers (MDP, DPD, HDP) in the osteogenic groups. Therefore all three tracers are of similar value when quantifying the extracellular hydroxylapatite content in osteogenic stem cells cultures.